Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track SHC with free AI briefings, catalyst countdowns, and dilution alerts.

SHC · Sotera Health Co

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$412.4M Cash on Hand
CF+ Cash Runway
Follow SHC by email Get an email when SHC reports key news in an SEC filing, pushes back a promised milestone, files for a stock offering, lands on the Downside Radar or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about SHC, unsubscribe in one click. Privacy

📄 Latest SEC Filings in Plain English

Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.

💰 Cash Runway & Dilution Risk

SHC holds $412.4M in cash and short-term investments (as of Sep 30, 2026) and its operations are currently cash-flow neutral or positive.

Dilution pressure: 0 · Low

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when SHC files for a raise →

👥 Who Owns SHC

Insiders 2.3% Other 5%+ holders 7.2% Institutions (431 holders) 90.5% Public and other holders 0%
HolderTypeShares% of sharesAs of
Sessa Capital IM, L.P. Institution (13G, 5%+) 27,050,000 9.47% 2026-06-30
Sculptor Capital LP Institution (13G, 5%+) 24,000,000 8.40% 2026-06-30
BlackRock, Inc. Institution (13G, 5%+) 23,845,504 8.35% 2026-06-30
Sessa Capital GP, LLC 5%+ holder (13G) 20,550,000 7.19% 2025-12-31
Vanguard Capital Management Institution (13G, 5%+) 14,625,165 5.12% 2026-09-30
Michael B. Jr. Petras
Executive Chairman, Director · +120,124 options
Insider 4,367,305 1.53% 2026-08-17
Alton Shader
Chief Executive Officer, Director · +101,817 options
Insider 579,573 0.20% 2026-05-26
Michael P Rutz
President of Sterigenics · +22,612 options
Insider 334,279 0.12% 2026-08-07
Alexander Dimitrief
Former SVP, GC and Sec. · +11,210 options
Insider 312,040 0.11% 2026-03-31
Jonathan M. Lyons
Sr. Vice President, CFO · +144,994 options
Insider 217,304 0.08% 2026-08-05
Ann R. Klee
Director
Insider 140,926 0.05% 2026-05-22
Ruoxi Chen
Director
Insider 95,751 0.03% 2026-05-22

Share count 285,630,846 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the total held by all 13F filers (Yahoo Finance); the table lists the largest. Sources have different dates, so the split is approximate. Source: SEC EDGAR.

Get the full SHC picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for SHC and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.